The current valuation score of cbdMD Inc is 8.18, ranking 101 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 0.03, which is 6389.06% below the recent high of 1.66 and 14444.53% above the recent low of -3.67.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.